Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PENPULIMAB Cause Myelosuppression? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Myelosuppression have been filed in association with PENPULIMAB (Penpulimab kcqx). This represents 36.8% of all adverse event reports for PENPULIMAB.

7
Reports of Myelosuppression with PENPULIMAB
36.8%
of all PENPULIMAB reports
1
Deaths
3
Hospitalizations

How Dangerous Is Myelosuppression From PENPULIMAB?

Of the 7 reports, 1 (14.3%) resulted in death, 3 (42.9%) required hospitalization, and 2 (28.6%) were considered life-threatening.

Is Myelosuppression Listed in the Official Label?

Yes, Myelosuppression is listed as a known adverse reaction in the official FDA drug label for PENPULIMAB.

What Other Side Effects Does PENPULIMAB Cause?

Anaemia (6) Thrombocytopenia (6) Diarrhoea (5) Leukopenia (5) Rash (5)

What Other Drugs Cause Myelosuppression?

CYCLOPHOSPHAMIDE (3,603) CARBOPLATIN (2,624) TRASTUZUMAB (2,552) PACLITAXEL (2,522) TISLELIZUMAB (2,142) CYTARABINE (1,869) VENETOCLAX (1,864) CISPLATIN (1,849) BEVACIZUMAB (1,744) SODIUM (1,696)

Related Pages

PENPULIMAB Full Profile All Myelosuppression Reports All Drugs Causing Myelosuppression PENPULIMAB Demographics